News

Integrated Proteins Limited will hold a board meeting on November 5, 2026, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026, along with a limited review report, according to a regulatory filing. The trading window for the company, with scrip code 519606, was closed from September 1, 2026, and will reopen 48 hours after the financial results are declared, on November 7, 2026.

Integrated Proteins Limited appointed Ms. Arushi Aggarwal as Company Secretary and Compliance Officer, designated as a Key Managerial Personnel, effective October 29, 2026, according to a filing with the BSE Limited on Tuesday.

Integrated Proteins Limited appointed Ms. Arushi Aggarwal as Company Secretary and Compliance Officer, designated as a Key Managerial Personnel, effective October 29, 2026, according to a filing with the BSE Limited on Tuesday.

Integrated Proteins Limited held its Annual General Meeting on September 30, 2026, via video conferencing, and approved the adoption of financial statements and the reappointment of Mr. Sandeep Mahadik as an Independent Director for a five-year term, commencing July 9, 2026, to July 8, 2031. The company also appointed Ms. Ankita Shah of Vast and Co., Company Secretaries LLP, as Secretarial Auditor for the financial year 2026-2027, and the voting results will be communicated to the BSE Limited by October 2, 2026.

Integrated Proteins Limited has set September 4, 2026, as the record date for the sub-division/split of its equity shares, transforming each Rs 10 share into 10 shares of Rs 1 each, a move approved by shareholders at an extraordinary general meeting on August 20, 2026.